Re: The Life Sciences Report Interview with George Zavoico (4/6/16)
in response to
by
No such message found
...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!
Message: The Life Sciences Report Interview with George Zavoico (4/6/16)
Your Vote:
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
George Zavoico is also one of the speakers at the NYAS Epigenetics Cancer and Beyond symposium on April 28th, 2016 in New York. I've pasted the afternoon portion of the agenda below, during which Resverlogix, Zenith and George Zavoico all present.
Plenary Session II: Epigenetic Therapies
|
1:30 PM |
Introduction |
|
1:35 PM |
Epigenetic Regulators as Dynamic Memory Devices |
|
2:10 PM |
EpiScience — Translating the Epigenetic Concept into Clinical Benefits |
|
2:45 PM |
Beneficial Effects of BET Inhibition on Cardiovascular Disease (preliminary title) |
|
3:20 PM |
Networking Coffee Break |
|
3:50 PM |
Preclinical Characterization of ZEN-3694, a Novel BET Bromodomain Inhibitor Entering Phase I Studies for Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
|
4:25 PM |
Targeting Chromatin Regulatory Pathways in Cancer |
|
5:00 PM |
Poster Prize Presentation and Closing Remarks |
|
5:10 PM |
Networking Reception |
|
6:00 PM |
Adjourn |
2 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply